Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma

BJU Int. 2008 Sep;102(6):747-55. doi: 10.1111/j.1464-410X.2008.07603.x. Epub 2008 Mar 10.

Abstract

Objective: To evaluate the presence of human papillomavirus (HPV) infection, the methylation status in the promoter region of thrombospondin-1 (TSP-1), RAS association domain family 1A (RASSF1-A) and p16 genes, and the expression of TSP-1, CD31, p16 and p53 proteins in patients diagnosed with penile cancer, and the possible associations between these variables and clinical and pathological features.

Patients and methods: HPV types, gene promoter hypermethylation and protein expression were analysed by reverse line blot, methylation-specific polymerase chain reaction, and immunohistochemistry, respectively, in 24 penile squamous cell carcinomas.

Results: HPV infection was detected in 11 of 24 cases (46%), and TSP-1, RASSF1-A and p16 genes were hypermethylated in 46%, 42% and 38% of the tumours, respectively. TSP-1 hypermethylation was associated with unfavourable histological grade (grade 3; P = 0.033), vascular invasion (P = 0.023), weak expression of TSP-1 protein (P = 0.041), and shorter overall survival (P = 0.04). TSP-1 expression was not associated with microvessel density. However, RASSF1-A hypermethylation was more frequent in T1 tumours (P = 0.01), and p16 hypermethylation was not associated with any of the tested variables except for absence of p16 expression (P = 0.022).

Conclusion: In summary, the epigenetic inactivation of TSP-1 and RASSF1-A genes is associated with pathological variables and seems to be of prognostic significance in penile cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • DNA Methylation*
  • Genes, p16
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Penile Neoplasms / genetics*
  • Penile Neoplasms / pathology
  • Prognosis
  • Promoter Regions, Genetic
  • Retrospective Studies
  • Thrombospondin 1 / genetics*
  • Tumor Suppressor Proteins / genetics*

Substances

  • RASSF1 protein, human
  • Thrombospondin 1
  • Tumor Suppressor Proteins